Public Policy, Regulation, Equity and Ethics

Introduction

Healthcare markets rarely produce socially acceptable outcomes without public policy. Unlike ordinary consumer goods, healthcare affects survival, human capability, dignity, family welfare and social participation. Patients often lack the information needed to judge quality, illness creates urgent and unpredictable demand, and providers may influence the choices of those who depend on them. These features create a strong economic and ethical case for collective action.

Healthcare policy must therefore address several questions simultaneously. Which services should be publicly supported? How should scarce resources be allocated? When should governments regulate prices, quality or professional conduct? How can competition be protected without undermining cooperation? Which inequalities are unjust, and which differences reflect legitimate choice or need? Finally, how should decision makers reconcile efficiency with equity, autonomy, solidarity and accountability?

This chapter examines these questions through the tools of health economics and public policy. It treats regulation not merely as legal compliance, but as an institutional design problem: rules should correct market failures while preserving innovation, responsiveness and professional responsibility.

Learning objectives

By the end of this chapter, readers should be able to:

1. Distinguish public goods, merit goods, private goods and common-pool resources in healthcare.
2. Explain externalities, information asymmetry, moral hazard and adverse selection as reasons for intervention.
3. Analyse taxation, insurance, subsidies and other redistributive instruments.
4. Evaluate price, quality, professional and market-structure regulation.
5. Explain antitrust concerns in hospitals, pharmaceuticals, insurance and digital health.
6. Apply priority-setting and rationing frameworks to real allocation decisions.
7. Distinguish equality from equity and analyse health inequalities using a social-determinants perspective.
8. Evaluate tensions among efficiency, equity, autonomy, solidarity and accountability.
9. Design ethically defensible and administratively feasible policy responses.

1. Why healthcare requires public policy

A perfectly competitive market assumes many buyers and sellers, informed decisions, freely available information, voluntary exchange and prices that reflect all relevant costs and benefits. Healthcare violates each assumption to some degree.

First, illness is uncertain. Individuals cannot predict when they will need expensive treatment, so risk pooling through insurance or taxation is valuable. Second, patients commonly have less clinical knowledge than providers. This information asymmetry may result in underuse, overuse or supplier-induced demand. Third, health has consequences for others. Vaccination can reduce transmission; untreated infectious disease can impose costs on the community; a healthy workforce can generate wider economic benefits. Fourth, ability to pay is not the same as ethical entitlement. A market may allocate care to those with greater purchasing power rather than those with greater need.

Public policy may therefore pursue four broad functions:

Policy intervention is not automatically beneficial. Governments may face limited information, political capture, administrative weakness and unintended consequences. The relevant comparison is not between an imperfect market and a perfect government, but between feasible institutional arrangements.

2. Public goods, merit goods and externalities

2.1 Economic classifications

A pure public good is both non-rivalrous and non-excludable. Non-rivalry means one person’s consumption does not reduce what is available to others; non-excludability means it is difficult to prevent non-payers from benefiting. National disease surveillance, population-level health intelligence and some forms of epidemic preparedness approximate public goods.

Most clinical services are private goods: treatment received by one patient is generally not simultaneously available to another, and access can usually be restricted. However, healthcare systems also contain merit goods. A merit good is considered socially important enough to justify provision beyond what individuals would purchase based only on private willingness to pay. Childhood immunisation, essential medicines and emergency care are common examples.

Some resources are common-pool resources: they are rivalrous but difficult to exclude people from using. A limited pool of donated organs is a healthcare example. Overuse or poorly designed allocation rules can produce unfair access and waste.

2.2 Externalities

An externality occurs when an action imposes a cost or creates a benefit for people not fully represented in the transaction. Vaccination creates a positive externality by reducing infection risk for others. Antimicrobial misuse creates a negative externality by accelerating resistance.

Let MB_p denote private marginal benefit and MB_s social marginal benefit. With a positive externality, the social benefit exceeds the private benefit:

Here MB_e is the marginal external benefit. The socially efficient quantity is found where social marginal benefit equals social marginal cost. If consumers consider only MB_p, market demand understates social value and the market quantity is too low. A subsidy, publicly funded service or mandate may move consumption toward the socially desirable level.

For a negative externality, social marginal cost exceeds private marginal cost:

where MC_e is the marginal external cost. Regulation, taxes, prescribing controls, surveillance and stewardship programmes can reduce socially harmful use. The equations are conceptual rather than directly measurable in many health systems; estimating external benefits and costs requires epidemiological, behavioural and economic evidence.

2.3 Information asymmetry and insurance failure

Patients often cannot assess the necessity, quality or likely outcome of care. Providers may act as agents, but their incentives may not perfectly match patient interests. Payment systems can intensify this problem: fee-for-service may encourage volume, while fixed budgets may encourage under-provision.

Insurance creates two additional concerns. Adverse selection occurs before enrolment when people with higher expected healthcare needs are more likely to purchase generous coverage. Moral hazard occurs after coverage when insured patients or providers face reduced financial consequences of additional use. Risk adjustment, enrolment mandates, benefit design, deductibles, clinical guidelines and provider payment reform are possible responses, although each can create access risks or administrative complexity.

3. Redistribution and social protection

Healthcare financing redistributes resources across income groups, health risks, age groups and generations. A system may be progressive, proportional or regressive depending on how contributions and benefits are distributed.

A progressive financing system takes a larger percentage of income from higher-income households. General taxation can achieve this when tax schedules are progressive. Social insurance may redistribute from low-risk to high-risk individuals and from working-age people to older or chronically ill populations. Means-tested subsidies target assistance according to income, but may create stigma, administrative burdens and incomplete coverage.

Universalism provides entitlement based on residence or membership in a social community rather than a narrow poverty test. Its advantages include broad risk pooling, reduced stigma and political durability. Its cost is that public resources also support people who could pay privately. Targeting and universalism are not mutually exclusive: a universal entitlement can be combined with additional support for groups facing greater need.

A useful financing identity is:

This is an accounting relationship, not a welfare measure. Two countries with identical total expenditure may differ substantially in financial protection, access, quality and equity. Out-of-pocket spending is particularly concerning when it causes catastrophic or impoverishing expenditure.

Redistribution should be assessed across the whole policy cycle: who pays, who receives services, who benefits in health terms, and who bears administrative or opportunity costs. A programme financed progressively may still be inequitable if its benefits are captured mainly by affluent groups with better information and easier access.

4. Regulation as institutional design

Regulation is the intentional use of authoritative rules to influence behaviour and outcomes. It may be implemented by governments, independent agencies, professional bodies or contracted organisations. Effective regulation requires a defined problem, a legitimate objective, suitable instruments, monitoring capacity and credible enforcement.

4.1 Types of regulation

Structural regulation controls who may provide care and with what resources. Licensing, facility registration, staffing requirements and capital standards are examples. Structural rules can protect safety but may also restrict entry and raise costs.

Process regulation specifies how care should be delivered. Clinical protocols, infection-control requirements, informed-consent rules and reporting duties fall into this category.

Outcome regulation focuses on results such as mortality, readmission, infection rates, patient-reported outcomes or waiting times. It can promote accountability but requires risk adjustment and careful measurement. Providers serving more complex patients may otherwise be unfairly penalised.

Economic regulation concerns prices, reimbursement, contracting and market entry. Price ceilings may protect consumers but can produce shortages if set below sustainable cost. Price floors may protect provider viability but increase spending. Negotiated prices, reference pricing, global budgets and competitive tendering each have different distributional and behavioural effects.

Information regulation requires disclosure of prices, ownership, conflicts of interest, quality indicators and data practices. Transparency is valuable only when information is understandable, timely and linked to meaningful choices.

4.2 Regulatory impact and proportionality

Regulation should be proportionate to risk. A low-risk digital appointment tool should not automatically face the same requirements as an autonomous diagnostic system or implantable device. Regulators should examine expected benefits, compliance costs, effects on innovation, distributional consequences and the likelihood of evasion.

A practical regulatory cycle is:

1. Define the harm or market failure.
2. Identify affected groups and rights.
3. Compare non-regulatory, co-regulatory and statutory options.
4. Select the least burdensome effective instrument.
5. Implement through clear standards and guidance.
6. Monitor outcomes and unintended effects.
7. Revise or withdraw ineffective rules.

5. Antitrust and competition in healthcare

Competition can improve efficiency, quality and innovation, but healthcare markets require special scrutiny. Hospitals may merge because of economies of scale, bargaining power or clinical integration. The same merger may also increase prices, reduce choice, weaken labour-market competition and make a system less resilient.

Antitrust analysis generally examines market definition, market power, competitive effects, efficiencies and the possibility of less restrictive alternatives. Relevant conduct includes:

• horizontal mergers between hospitals or insurers;
• vertical integration between insurers, hospitals, pharmacies and physicians;
• exclusionary contracting or refusal to deal;
• tying, bundling and loyalty rebates;
• information exchange that facilitates collusion;
• excessive concentration in labour markets for nurses or specialists.

Healthcare competition should not be evaluated solely by price. Quality, access, continuity, innovation, clinical integration and equity are also relevant. At the same time, claims of “integration” should be tested rather than accepted automatically. A clinically integrated network may improve coordination; it may also conceal collective price negotiation that harms purchasers.

Public purchasers should use competitive procurement carefully. Lowest price is not necessarily best value. Contracts can include quality thresholds, continuity requirements, workforce standards, data portability and remedies for poor performance.

6. Priority setting and rationing

Rationing exists whenever beneficial healthcare cannot be provided to everyone at the desired level. It occurs explicitly through coverage decisions and waiting lists, or implicitly through prices, distance, administrative complexity and provider discretion. Denying that rationing exists often makes it less transparent and less accountable.

Priority setting is the broader process of deciding which services, populations and outcomes receive precedence. Common criteria include:

• expected health benefit;
• severity and urgency of illness;
• cost-effectiveness;
• protection of disadvantaged groups;
• catastrophic financial risk;
• feasibility and opportunity cost;
• respect for individual rights and procedural fairness.

Cost-effectiveness analysis often uses the incremental cost-effectiveness ratio:

Here C₁ and C₀ are the costs of a new and comparator intervention, while E₁ and E₀ are their health outcomes. Costs must be measured in the same currency and perspective, and outcomes in the same unit, such as life-years or quality-adjusted life-years. The ratio is meaningful only when the new intervention is more effective and the comparison is appropriate. A threshold may assist decisions, but it is not a universal law and should not replace deliberation about equity, uncertainty and budget impact.

A quality-adjusted life-year, or QALY, combines length and health-related quality of life. In a simplified case:

where utility_t ranges conventionally from 0 for death to 1 for full health, and time_t is the duration in the relevant health state. The measure is useful for comparing diverse interventions, but critics argue that it may disadvantage people with disabilities, older people or those requiring expensive long-term care unless supplemented by equity considerations.

Fair priority setting requires publicity, relevance, revision and enforcement. These principles are often called accountability for reasonableness. Decisions should be publicly explainable, based on reasons that fair-minded stakeholders can accept, revisable when evidence changes, and subject to oversight.

7. Equity and health inequalities

Equality means treating people identically or distributing resources equally. Equity concerns fairness and may require unequal treatment when needs, barriers or expected benefits differ. Equal health outcomes are not always feasible or ethically required; equitable policy seeks to reduce avoidable, unfair and systematic differences.

Health inequalities may be described by income, education, geography, ethnicity, gender, disability, migration status, occupation or social position. A social-determinants framework distinguishes structural determinants—such as political institutions, labour markets and discrimination—from intermediary determinants such as housing, nutrition, employment conditions, stress and access to care.

The inverse care law describes the tendency for availability of good medical care to vary inversely with population need, particularly where provision is shaped strongly by market purchasing power. Universal coverage does not automatically eliminate this problem. Transport, language, digital access, trust, opening hours and discrimination can continue to produce unequal effective access.

Policy responses include progressive financing, primary-care investment, risk-adjusted funding, geographically weighted resource allocation, culturally safe services, disability accommodation and action on housing, education and employment. Equity impact assessment should ask:

1. Who gains and who loses?
2. Are effects different across social groups?
3. Do administrative requirements exclude people?
4. Can affected communities participate in design and review?
5. Are outcomes measured, not merely spending levels?

8. Ethical tensions in healthcare policy

Efficiency and equity

Efficiency concerns obtaining the greatest total benefit from available resources. Equity concerns fair distribution of benefits, burdens and opportunities. A policy can be efficient but inequitable, or equitable in distribution but inefficient in production. The practical challenge is not to choose one value universally, but to make trade-offs explicit.

Autonomy and paternalism

Respect for autonomy supports informed choice, privacy and control over personal information. Paternalistic interventions limit choice to prevent harm or promote welfare. Vaccination mandates, compulsory treatment and restrictions on harmful prescribing may be justified when risks to others are substantial, evidence is strong, less restrictive alternatives are inadequate, and exemptions or due process are available.

Solidarity and individual responsibility

Solidarity treats health risks as partly shared social concerns. It supports collective financing and protection of vulnerable people. Responsibility-sensitive approaches ask individuals to bear consequences for risky choices. Such approaches can be problematic because behaviour is shaped by income, advertising, trauma, genetics and environment. Solidarity does not eliminate personal responsibility, but it limits moral judgement as a basis for denying essential care.

Confidentiality and accountability

Confidentiality protects trust and privacy. Accountability may require reporting adverse events, public-health notifications, audit data or disclosure of conflicts. Ethical governance uses necessity, proportionality, data minimisation, security controls and transparent legal authority to reconcile these values.

Procedural and substantive justice

Substantive justice concerns the distribution of health and healthcare. Procedural justice concerns how decisions are made. Participation, reasons, consistency, appeal and independent review are especially important when decisions affect life, disability or access to essential treatment.

9. Digital health, AI and governance

Digital systems can improve access, coordination and population surveillance, but they can also reproduce historical discrimination. An algorithm trained on unequal utilisation data may interpret lower recorded spending as lower need. Predictive tools may perform differently across racial, linguistic, socioeconomic or disability groups.

Governance should include a defined purpose, validated performance, subgroup testing, human oversight, explainable decision pathways, cybersecurity, data minimisation, procurement accountability and mechanisms for contesting decisions. Automation should not remove responsibility from institutions. A hospital remains accountable for how a clinical tool is selected, monitored and used.

AI regulation should be risk-based. High-impact systems used for diagnosis, eligibility, triage or resource allocation require stronger documentation, independent evaluation and post-deployment surveillance than low-risk administrative tools. Equity analysis should examine both model accuracy and the consequences of errors: a false negative may delay treatment, while a false positive may consume scarce capacity.

10. Illustrative case: Regional hospital consolidation and emergency access

Background

A fictional region contains two hospitals serving 450,000 residents. Hospital A is urban and financially stable; Hospital B is smaller, rural and facing workforce shortages. The hospitals propose a merger. They argue that consolidation will support specialist recruitment, shared procurement and coordinated emergency services.

Problem

The proposed merger would create the dominant provider for inpatient care. An independent assessment finds likely efficiency gains but also predicts higher bargaining power over public purchasers, reduced local choice and the possible closure of Hospital B’s emergency department. Rural residents would face longer travel times, while the merger’s financial benefits would be concentrated in the urban system.

Analysis

The case contains several market and ethical issues. Economies of scale may reduce duplicated overhead, but clinical scale economies are not automatic. Emergency access has a public-interest dimension because delay affects people who cannot choose their location or time of illness. The relevant comparison is not simply merger versus no merger; alternatives include a formal clinical network, shared back-office functions, joint recruitment, telemedicine and public funding tied to rural emergency capacity.

An equity impact assessment should examine travel time by income, age, disability and transport access. An antitrust review should define relevant geographic and service markets, assess buyer and provider power, and test whether claimed efficiencies require full ownership integration.

Approach and solution

The regulator conditionally approves a limited network rather than an unrestricted merger. The agreement includes:

• guaranteed emergency coverage at Hospital B;
• transparent quality and waiting-time reporting;
• independent review of referral and transfer performance;
• limits on exclusive contracting;
• shared procurement without unnecessary foreclosure of suppliers;
• community representation in governance;
• a five-year review with powers to impose remedies.

Outcome

After three years, specialist recruitment improves and procurement costs fall. Emergency access is maintained, but the regulator identifies unequal use of telemedicine among older residents and people without broadband. Additional transport and assisted digital services are funded.

Learning points

Efficiency claims must be tested against distributional effects. Competition policy should consider access and quality, not only prices. Conditional approval can preserve benefits while controlling risks. Finally, accountability requires monitoring after implementation; a decision that is reasonable ex ante may require correction when evidence changes.

11. Managerial implications and best practices

Healthcare managers operate within policy constraints but also shape policy outcomes. Good practice includes:

• mapping stakeholders, rights and distributional effects before major decisions;
• distinguishing legal compliance from ethical adequacy;
• using evidence proportionate to the decision’s stakes;
• documenting assumptions, uncertainty and opportunity costs;
• incorporating patient and community participation early;
• designing contracts with measurable quality and equity indicators;
• monitoring unintended exclusion and supplier responses;
• protecting whistleblowers and conflict-of-interest processes;
• using independent review for high-impact allocation decisions;
• treating data quality and interoperability as governance responsibilities;
• revising policies when evidence, technology or social conditions change.

Managers should also avoid common errors: using average outcomes to conceal subgroup harm, treating cost-effectiveness thresholds as automatic decisions, confusing equal inputs with equitable access, and adopting technology without assessing who may be excluded.

Challenges and limitations

Public policy analysis is limited by incomplete evidence, uncertain causal relationships and contested values. Externalities may be difficult to quantify. Cost-effectiveness results depend on perspective, time horizon, discounting, outcome measurement and distributional assumptions. Regulation can generate compliance costs, strategic gaming and barriers to entry. Antitrust remedies may be slow, while market power can be difficult to define in multisided digital markets. Participation can improve legitimacy but may favour groups with more time, confidence or organisational resources.

Ethical frameworks do not produce mechanically correct answers. They clarify reasons and expose trade-offs. A defensible decision is therefore not one that claims to maximise a single value, but one that uses evidence, respects rights, explains its rationale, distributes burdens fairly and remains open to revision.

Chapter Summary

Healthcare policy responds to market failures, social objectives and ethical obligations. Public goods and externalities justify collective action; information asymmetry, insurance problems and provider power complicate market allocation. Redistribution through taxation, social insurance and subsidies can improve financial protection, but equity must be assessed across financing, access and outcomes.

Regulation may address structure, process, outcomes, prices and information. It should be proportionate, evidence-informed and subject to monitoring. Antitrust policy must consider concentration, vertical integration, quality, access and innovation. Priority setting and rationing are unavoidable where resources are limited; transparent criteria, cost-effectiveness analysis and fair procedures improve legitimacy.

Equity differs from equality and requires attention to social determinants and unequal barriers. Healthcare governance must reconcile efficiency with equity, autonomy, solidarity and accountability. Digital and AI systems add opportunities but require risk-based oversight, subgroup evaluation and human responsibility. Effective managers make trade-offs explicit, engage affected communities and revise decisions as evidence changes.

Key Terms

Public good: A good that is non-rivalrous and non-excludable.

Merit good: A socially valued good that may be provided beyond market demand.

Externality: A cost or benefit imposed on others outside a transaction.

Information asymmetry: Unequal information between parties to an exchange.

Adverse selection: Risk-related enrolment differences occurring before insurance coverage.

Moral hazard: Behavioural change after insurance reduces the financial consequences of use.

Redistribution: Transfer of resources or opportunities among individuals or groups.

Universalism: Entitlement based broadly on membership or residence rather than narrow means testing.

Regulation: Authoritative rules intended to influence conduct or outcomes.

Accreditation: Formal recognition that an organisation meets specified standards.

Antitrust: Legal and economic policy protecting competition and limiting abusive market power.

Market power: The ability to influence prices, quality, supply or conditions of exchange.

Priority setting: Deliberation about which services, populations or outcomes receive precedence.

Rationing: Allocation of scarce healthcare in circumstances where not all beneficial care can be provided.

Cost-effectiveness analysis: Comparison of incremental costs and health outcomes between alternatives.

QALY: A measure combining duration and quality of health.

Equity: Fairness in the distribution of health, care, benefits and burdens.

Solidarity: Collective responsibility for shared social risks.

Accountability for reasonableness: A framework requiring transparent, relevant, revisable and enforceable allocation decisions.

Review Questions

Short Answer Questions

1. What distinguishes a public good from a private healthcare good?
2. Explain the difference between adverse selection and moral hazard.
3. Why might a healthcare merger raise antitrust concerns?
4. What is meant by equity in healthcare?
5. Identify two requirements of accountability for reasonableness.

Long Answer Questions

1. Analyse the economic and ethical justifications for public financing of vaccination.
2. Compare structural, process, outcome and economic regulation in healthcare.
3. Explain how taxation and social insurance redistribute healthcare resources.
4. Discuss the strengths and limitations of QALYs in priority setting.
5. Evaluate the tensions among efficiency, equity, autonomy and solidarity.

Analytical / Application Questions

1. A government is considering a subsidy for a preventive service with substantial community benefits. Use externality theory to analyse the policy and identify possible unintended effects.
2. A rural hospital merger promises lower costs but may increase travel time for disadvantaged residents. Design an antitrust and equity assessment.
3. An AI triage tool produces fewer referrals for a low-income population. Propose a governance investigation, identify possible explanations and recommend corrective action.

Multiple Choice Questions with Answers

Question 1

Which feature most directly characterises a pure public good?

A. It is rivalrous and excludable.

B. It is non-rivalrous and non-excludable.

C. It is purchased only through insurance.

D. It always produces a positive externality.

Correct Answer: B. It is non-rivalrous and non-excludable.

Question 2

Vaccination is commonly subsidised because it produces which economic effect?

A. A negative externality only

B. A positive externality

C. Perfect price discrimination

D. Adverse selection

Correct Answer: B. A positive externality

Question 3

Adverse selection occurs primarily when:

A. Insurance changes behaviour after enrolment.

B. Providers reduce quality after payment.

C. People with higher expected costs are more likely to seek coverage before enrolment.

D. Governments regulate prices below cost.

Correct Answer: C. People with higher expected costs are more likely to seek coverage before enrolment.

Question 4

Which is an example of outcome regulation?

A. Professional licensing

B. A staffing qualification rule

C. Mandatory infection-control procedures

D. Monitoring risk-adjusted mortality rates

Correct Answer: D. Monitoring risk-adjusted mortality rates

Question 5

The purpose of antitrust policy in healthcare is primarily to:

A. Guarantee that every provider earns the same profit.

B. Protect competition and limit harmful market power.

C. Eliminate all forms of provider integration.

D. Require patients to purchase private insurance.

Correct Answer: B. Protect competition and limit harmful market power.

Question 6

In the formula ICER = (C₁ − C₀) ÷ (E₁ − E₀), E₁ − E₀ represents:

A. The incremental cost

B. The total budget

C. The incremental health effect

D. The insurance premium

Correct Answer: C. The incremental health effect

Question 7

Which statement best distinguishes equity from equality?

A. Equity always means identical treatment.

B. Equality considers need, while equity ignores it.

C. Equity concerns fairness and may justify different support according to need.

D. They are economic terms with no ethical meaning.

Correct Answer: C. Equity concerns fairness and may justify different support according to need.

Question 8

Which principle is central to accountability for reasonableness?

A. Decisions must remain secret.

B. Decisions should be based on publicly defensible reasons.

C. Only cost should determine priorities.

D. Decisions must never be revised.

Correct Answer: B. Decisions should be based on publicly defensible reasons.

Question 9

A negative externality of antimicrobial misuse is:

A. Reduced resistance in the population.

B. Increased benefit to unrelated consumers.

C. Acceleration of antimicrobial resistance affecting others.

D. Elimination of information asymmetry.

Correct Answer: C. Acceleration of antimicrobial resistance affecting others.

Question 10

A risk-based approach to AI governance implies that:

A. Every algorithm requires identical regulation.

B. High-impact clinical systems warrant stronger oversight than low-risk administrative tools.

C. Human oversight is unnecessary after validation.

D. Accuracy eliminates all ethical concerns.

Correct Answer: B. High-impact clinical systems warrant stronger oversight than low-risk administrative tools.